- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Futibatinib is a targeted anti-cancer drug, and its use must strictly follow contraindications, foods, and restrictions to ensure efficacy and ...
Futibatinib is a targeted FGFR kinase inhibitor used to treat specific cancer patients. The following will provide a detailed explanation of it...
Everolimus is an mTOR inhibitor with anti-tumor and immunomodulatory effects, mainly used to treat specific cancers and rejection reactions aft...
Everolimus, as an mTOR inhibitor, has shown significant efficacy in various indications, but standardized discontinuation is necessary to avoid...
Sorafenib, as a multi kinase inhibitor, has clear contraindications, dietary restrictions, and medication constraints when used. This article w...
Sorafenib, as a multi-target kinase inhibitor, has side effects that involve multiple systems and require targeted mitigation measures. This ar...
Anagrelide, as a specific drug for the treatment of thrombocytosis, should be adjusted in dosage and administration according to patient type a...
Anagrelide is effective in treating thrombocytosis, but attention should be paid to the risk of rebound thrombocytosis when discontinuing the m...
The usage and dosage of Febuxostat, as well as the medication for special populations, need to be adjusted according to the individual patient'...
Febuxostat, as a uric acid lowering drug, mainly has side effects in the liver, cardiovascular system, and allergic reactions, which need to be...
